[A21-41] Clopidogrel, prasugrel, and ticagrelor for the prevention of atherothrombotic events in acute coronary syndrome

Last updated 22.02.2023

Project no.:
A21-41

Commission:
Commission awarded on 01.04.2021 by the Federal Joint Committee (G-BA).

Report type:
Rapid report

Status:
Commission completed

Department/Division:
Drug Assessment

Topic:
Heart and circulation

22.02.2023

One drug manufacturer did not provide the requested additional data. However, exploratory analyses show that these would have been important.

Press release

Rapid Report: Clopidogrel, prasugrel, and ticagrelor for the prevention of atherothrombotic events in acute coronary syndrome.

EN, PDF, 852 kB, PDF

published on Feb 22, 2023

Contact

Press contact

+49 221 356850

presse@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.